Press Releases

BIRMINGHAM, Ala. – Earnest Tate is no stranger to adversity or history. When he was named the first black police chief of Selma in the late 1990s, he had  to lead and unify a police force that had been heavily scrutinized  during the civil rights era. 

Life-Saving Technology Designed for Safety, Stability and Procedural Control.

Endologix Treats 5,000 AAA Patients with Nellix® Endovascular Aneurysm Sealing System.

ST. LOUIS, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, and University Medical Center (UMC) New Orleans, the academic medical center of LCMC Health, today announced the first procedures performed using the Stereotaxis suite of products for electrophysiology (EP) ablation at UMC. The platform includes the Niobe® ES remote magnetic navigation system, the Vdrive® robotic navigation system and Odyssey® information management solutions for lab optimization.

Move Your Mountain will host an online Story Submission Contest for a chance to win a Grand Prize of $1,000.

Interactive Health, a national leader for its personalized wellness solutions, announced today it is supporting the American Heart Association on a shared mission of improving health and reducing heart disease risk and death.

RIDGEFIELD, Conn. and INDIANAPOLIS, Jan. 25, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) accepted a supplemental New Drug Application for Jardiance® (empagliflozin) based on cardiovascular risk reduction data from the landmark EMPA-REG OUTCOME® trial. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) expect to receive a decision from the FDA within the standard review time frame.

SANTA CLARA, Calif., Jan. 25, 2016 /PRNewswire/ -- Advanced Cardiac Therapeutics, Inc. ("ACT"), a developer and manufacturer of a proprietary and unique open-irrigated radio frequency ("RF") ablation technology, announced today that its technology has been successfully used to treat 12 patients suffering from Atrial Fibrillation ("AFIB") in Prague, Czech Republic.  The ACT first-in-man study was designed to evaluate the safety and effectiveness of the ACT system.  The patients were treated by the study's principal investigator, Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mount Sinai Hospital.

Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the OsteoCool(TM) RF Ablation System.

Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today announced that the IN.PACT® Admiral® drug eluting balloon (DEB) (also known as the IN.PACT Admiral drug-coated balloon (DCB) in non-European markets) has received CE (Conformité Européene) Mark for arteriovenous (AV) access to help maintain hemodialysis access in patients with end-stage renal disease. 

In a newly published KLAS report entitled "Global HIT Trends: Which Vendors are Providers Betting On?" KLAS interviewed providers around the world to better understand their EMR purchasing plans.

Medtronic (NYSE: MDT) today announced that the University of Washington and King County (Seattle) Emergency Medical Services will lead the U.S. expansion of the HeartRescue Project, a successful Medtronic Philanthropy partnership launched in five states in 2010 that brought together some of the nation's leading resuscitation experts to improve survival rates for Sudden Cardiac Arrest (SCA).

Databound Healthcare Solutions announced today the availability of reCover, a fully-managed claim recovery solution that enables Indian Health Services (IHS) hospitals to find additional insurance payers and see higher returns. 

Medtronic plc (NYSE: MDT) today announced that its Micra® Transcatheter Pacing System (TPS) and Hybrid Closed Loop system have both earned the 2015 'Best of What's New' award in the health category by Popular Science, the world's largest science and technology magazine.

Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of an independent multicenter study on the procedural benefits and outcomes of patients undergoing radiofrequency ablation therapy for ventricular tachycardia (VT) using the Niobe® remote magnetic navigation system compared to manual catheter approaches.

Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial availability of the MyCareLink Smart(TM) Monitor, the world's first app-based remote monitoring system for patients with implantable pacemakers.

Selected for nearly one of every two endovascular abdominal aortic aneurysm (AAA) repairs globally, the Endurant® AAA stent graft system from Medtronic plc (NYSE: MDT) continues to maintain durable and consistent outcomes at four years in real world settings, including challenging anatomies.

Medtronic plc (NYSE: MDT) today announced notable clinical studies and innovative technologies that will be presented at the annual VEITHsymposium, the world's premier conference for vascular surgeons specializing in the most current information and new developments in clinical practice and research. 

Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2015 in Orlando, Fla.

Merit Medical Systems, Inc. and its renowned ThinkRadial™ education program, now offers a new, one-of-a-kind vascular training model at events throughout the world. 

Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the successful outcome of the first-in-man clinical EVAR case using its new low profile IntelliFlex(TM) LP Delivery System to deploy its endovascular stent graft, Aorfix(TM).